LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/DePuy Synthes: First 3D Simulation for Limb Deformity Patients
Large Joints and Extremities

DePuy Synthes: First 3D Simulation for Limb Deformity Patients

October 26, 2017 2 min read Premium comments

Advertisement

DePuy Synthes: First 3D Simulation for Limb Deformity Patients
Courtesy of DePuy Synthes
Secondary

DePuy Synthes has launched the first 3D simulation-assisted orthopedic external circular fixation device for limb deformity patients.

As the company wrote in its October 11, 2017 news release, “Unlike other computer-assisted external circular fixation systems, the MAXFRAME System’s 3D planning software creates accurate patient treatment plans using advanced algorithms, which eliminates the need for manual measurements and requires fewer inputs than any other system on the market. This can potentially lead to a reduction in the number of patient X-rays required, thus reducing procedural complexity, radiation exposure for both the patient and surgeon, and overall costs, while reducing treatment time for the patient.”

Those using the MAXFRAME System can adjust the struts on the device themselves. As noted in the news release, “These adjustments have been made easier with the system’s newly introduced ASSURE-STRUT Technology, wherein each time the patient adjusts the device, there is an audible click as the strut correctly locks into place. To support patients, DePuy Synthes has developed the MAXFRAME Patient Care Program, which includes a patient app featuring a character named “MAX,” and additional online content is available at www.maxframepatients.com.”

“The MAXFRAME System is indicated for the following treatments in adults and in both children (3-12) and adolescents (12-21) in which the growth plates have fused or will not be crossed with hardware: fracture fixation (open and closed), pseudoarthrosis of long bones, limb lengthening (epiphyseal or metaphyseal distraction), joint arthrodesis, infected fractures or nonunions, correction of bony or soft tissue deformities, and correction of segmental defects.”

I.V. Hall, Worldwide Platform Leader, Trauma, CMF [craniomaxillofacial], Biomaterials and Veterinary Portfolios, DePuy Synthes, commented to OTW, “Throughout the development phase we were reminded of our commitment to bring a different and new solution to expand DePuy Synthes capabilities in helping these patients who have been suffering from limb deformity, and that we were in the process of bringing a technology to market that could advance successful treatment.”

“MAXFRAME works to reduce the burden for both the surgeon and the patient during all phases of treatment. The device’s unique 3D [three dimensional] software helps surgeons achieve greater accuracy with fewer measurements, and the ASSURE-STRUT Technology helps patients confidently make the prescribed adjustments to the device per their treatment plan.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy